Integrative analyses reveal novel strategies in HPV11,-16 and -45 early infection

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Kaczkowski, Bogumil ^a   Rossing, Maria ^b   Andersen, Ditte K ^a   Dreher, Anita ^a   Morevati, Marya ^a   Visser, Melissa A ^a   Winther, Ole ^a,c   Nielsen, Finn Cilius ^b   Norrild, Bodil ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Mental Health Services CPH   (Denmark)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOLOGY; CELL LINE; CYTOPATHOGENIC EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; METHODOLOGY; PAPILLOMA VIRUS; PROTEIN PROTEIN INTERACTION; VIRUS CELL TRANSFORMATION; VIRUS REPLICATION;

CELL LINE; CELL TRANSFORMATION, VIRAL; COMPUTATIONAL BIOLOGY; CYTOPATHOGENIC EFFECT, VIRAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; GENE REGULATORY NETWORKS; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 11; HUMAN PAPILLOMAVIRUS 16; HUMANS; PAPILLOMAVIRIDAE; PROTEIN INTERACTION MAPS; VIRUS REPLICATION;

EID: 84864137279     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00515     Document Type: Article

References (53)

1. Hausen, zur, H. Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes. Semin. Cancer Biol. 9, 405-411 (1999).
2. Chow, L. T., Broker, T. R. & Steinberg, B. M. The natural history of human papillomavirus infections of the mucosal epithelia. APMIS 118, 422-449 (2010).
3. Doorbar, J. et al. Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line. Virology 178, 254-262 (1990). (Pubitemid 20276690)
4. Antinore, M. J., Birrer, M. J., Patel, D., Nader, L. & McCance, D. J. The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors. EMBO J. 15, 1950-1960 (1996). (Pubitemid 26119228)
5. Ghittoni, R. et al. The biological properties of E6 and E7 oncoproteins from human papillomaviruses. Virus Genes 40, 1-13 (2010).
6. . Santegoets, L. A. M. et al.DifferentDNAdamage and cell cycle checkpoint control in low-and high-risk human papillomavirus infections of the vulva. Int. J. Cancer (2011).doi:10.1002/ijc.26345
7. Santin, A., Zhan, F., Bignotti, E., Siegel, E. & Cané, S. Gene expression profiles of primary HPV16-and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virology (2005).
8. DeVoti, J. A. et al. Immune dysregulation and tumor-associated gene changes in recurrent respiratory papillomatosis: a paired microarray analysis. Mol. Med. 14, 608-617 (2008).
9. Alazawi, W. et al. Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16. Cancer Res. 62, 6959-6965 (2002). (Pubitemid 35424087)
10. Chang, Y. E. & Laimins, L. A. Interferon-inducible genes are major targets of human papillomavirus type 31: insights from microarray analysis. Dis. Markers 17, 139-142 (2001). (Pubitemid 34014689)
11. Thomas, J. T., Oh, S. T., Terhune, S. S. & Laimins, L. A. Cellular changes induced by low-risk human papillomavirus type 11 in keratinocytes that stably maintain viral episomes. Journal of Virology 75, 7564-7571 (2001). (Pubitemid 32738014)
12. Karstensen, B., Poppelreuther, S., Bonin, M. & Walter, M. Gene expression profiles reveal an upregulation of E2F and downregulation of interferon targets byHPV18 but no changes between keratinocytes with integrated or . Virology (2006).
13. Nees, M. et al. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NFkappaB-responsive genes in cervical keratinocytes. Journal of Virology 75, 4283-4296 (2001). (Pubitemid 32410141)
14. Boccardo, E. et al. Expression of human papillomavirus type 16 E7 oncoprotein alters keratinocytes expression profile in response to tumor necrosis factor. Carcinogenesis 31, 521-531 (2010).
15. Garner-Hamrick, P. A. et al. Global effects of human papillomavirus type 18 E6/E7 in an organotypic keratinocyte culture system. Journal of Virology 78, 9041-9050 (2004). (Pubitemid 39096515)
16. Guan, P., Jones, R. H. & Li, N. Human papillomavirus (HPV) types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer -Guan -International Journal of Cancer -Wiley Online Library. Journal of Cancer (2012).
17. Lisboa, F. A. et al. Pregnancy-specific glycoprotein 1 induces endothelial tubulogenesis through interaction with cell surface proteoglycans. J. Biol. Chem. 286, 7577-7586 (2011).
18. Chu, W., Burns, D. K., Swerlick, R. A. & Presky, D. H. Identification and characterization of a novel cytokine-inducible nuclear protein from human endothelial cells. J. Biol. Chem. 270, 10236-10245 (1995).
19. Wathelet, M. G., Clauss, I. M., Content, J. & Huez, G. A. Regulation of two interferon-inducible human genes by interferon, poly(rI).poly(rC) and viruses. Eur. J. Biochem. 174, 323-329 (1988).
20. Nomura, D. K. et al. Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer. Chem. Biol. 18, 846-856 (2011).
21. Ming-Ju, H., Yih-Shou, H., Tzy-Yen, C. & Hui-Ling, C. Hepatitis C virus E2 protein induce reactive oxygen species (ROS)-related fibrogenesis in the HSC-T6 hepatic stellate cell line. J. Cell. Biochem. 112, 233-243 (2011).
22. Kitamura, A., Takahashi, K., Okajima, A. & Kitamura, N. Induction of the human gene for p44, a hepatitis-C-associated microtubular aggregate protein, by interferon-alpha/beta. Eur. J. Biochem. 224, 877-883 (1994). (Pubitemid 24288849)
23. Hallen, L. C. et al. Antiproliferative activity of the human IFN-alpha-inducible protein IFI44. J. Interferon Cytokine Res. 27, 675-680 (2007). (Pubitemid 350194564)
24. Schoggins, J. W. et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481-485 (2011).
25. Miyashita, M., Oshiumi, H., Matsumoto, M. & Seya, T. DDX60, a DEXD/H box helicase, is a novel antiviral factor promoting RIG-I-like receptor-mediated signaling. Mol. Cell. Biol. 31, 3802-3819 (2011).
26. Gladue, D. P. et al. Patterns of gene expression in swine macrophages infected with classical swine fever virus detected by microarray. Virus Res. 151, 10-18 (2010).
27. Pujana, M. A. et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat. Genet. 39, 1338-1349 (2007). (Pubitemid 350035000)
28. Katoh, K., Kano, Y. & Noda, Y. Rho-associated kinase-dependent contraction of stress fibres and the organization of focal adhesions. J R Soc Interface 8, 305-311 (2011).
29. Côté-Martin, A. et al. Human papillomavirus E1 helicase interacts with the WD repeat protein p80 to promote maintenance of the viral genome in keratinocytes. Journal of Virology 82, 1271-1283 (2008).
30. Dreher, A. et al.Differential expression of cellular microRNAs inHPV11, -16, and -45 transfected cells. Biochemical and Biophysical Research Communications 412, 20-25 (2011).
31. Dreher, A., Rossing, M., Kaczkowski, B., Nielsen, F. C. & Norrild, B. Differential expression of cellular microRNAs in HPV-11 transfected cells. An analysis by three different array platforms and qRT-PCR. Biochemical and Biophysical Research Communications 403, 357-362 (2010).
32. Iftner, T. et al. Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1. EMBO J. 21, 4741-4748 (2002). (Pubitemid 34984361)
33. Stanley, M. A. Immune responses to human papilloma viruses. Indian J. Med. Res. 130, 266-276 (2009).
34. Haller, O., Staeheli, P. & Kochs, G. Interferon-induced Mx proteins in antiviral host defense. Biochimie 89, 812-818 (2007). (Pubitemid 47001645)
35. Reiser, J. et al. High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression. Journal of Virology 85, 11372-11380 (2011).
36. Daud, I. I. et al. Association between toll-like receptor expression and human papillomavirus type 16 persistence. Int. J. Cancer 128, 879-886 (2011).
37. Li, S. et al. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene 18, 5727-5737 (1999). (Pubitemid 29507426)
38. Devergne, O. et al. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. Journal of Virology 70, 1143-1153 (1996). (Pubitemid 26029036)
39. Scanga, C., Cardellichio, C. & Holmes, K. Expression of the recombinant anchorless N-terminal domain of mouse hepatitis virus (MHV) receptor makes hamster of human cells susceptible to MHV infection. Journal of (1996).
40. Chen, D. S. et al. A pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virus. Proc. Natl. Acad. Sci. U.S.A. 92, 12095-12099 (1995). (Pubitemid 26014018)
41. Blinov, V., Resenchuk, S. & Chirikova, G. Possible role of pregnancy-specific glycoprotein (PSG) in mother-child HIV infection transfer ( Conference On Aids: 1994).
42. Taylor, M. P., Koyuncu, O. O. & Enquist, L. W. Subversion of the actin cytoskeleton during viral infection. Nat. Rev. Microbiol. 9, 427-439 (2011).
43. Alam,H.H., Sehgal, L. L., Kundu, S. T. S., Dalal, S. N. S. & Vaidya, M. M. M. Novel function of keratins 5 and 14 in proliferation and differentiation of stratified epithelial cells. CORD Conference Proceedings 22, 4068-4078 (2011).
44. Cooper, D. & Schermer, A. Biology of disease. Laboratory investigation (1985).
45. Arnouk, H. et al. Characterization of Molecular Markers Indicative of Cervical Cancer Progression. Proteomics Clin Appl 3, 516-527 (2009).
46. Janes, S. M., Ofstad, T. A., Campbell, D. H.,Watt, F. M. & Prowse, D. M. Transient activation of FOXN1 in keratinocytes induces a transcriptional programme that promotes terminal differentiation: contrasting roles of FOXN1 and Akt. J. Cell. Sci. 117, 4157-4168 (2004). (Pubitemid 39328303)
47. Talora, C., Sgroi, D. & Crum, C. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. Genes & development (2002).
48. Hose, D. et al. Induction of angiogenesis by normal and malignant plasma cells. Blood 114, 128-143 (2009).
49. Carvalho, B. S. & Irizarry, R. A. A framework for oligonucleotide microarray preprocessing. Bioinformatics 26, 2363-2367 (2010).
50. Smyth, G. K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3,Article3 (2004).
51. Beisser, D., Klau, G. W., Dandekar, T., Muller, T. & Dittrich, M. T. BioNet: an R-Package for the functional analysis of biological networks. Bioinformatics 26, 1129-1130 (2010).
52. Dittrich, M. T., Klau, G. W., Rosenwald, A., Dandekar, T. & Muller, T. Identifying functional modules in protein-protein interaction networks: an integrated exact approach. Bioinformatics 24, i223-i231 (2008). (Pubitemid 351911677)
53. Cline, M. S. et al. Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2, 2366-2382 (2007)